Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 1842 entries
Sorted by: Best Match Show Resources per page
Cor triatriatum dexter with atrial septal defect evaluated by real-time three-dimensional transesophageal echocardiography.

Journal of echocardiography

Yamaguchi R, Ota T, Tanigawa T, Sakai M, Norioka N, Ishikawa S, Kawai K, Nishiyama H, Tsumori T, Kamimori K, Yanagi S.
PMID: 27278516
J Echocardiogr. 2013 Jun;11(2):77-9. doi: 10.1007/s12574-013-0172-2. Epub 2013 Mar 23.

No abstract available.

Cite
Yamaguchi R, Ota T, Tanigawa T, et al. Cor triatriatum dexter with atrial septal defect evaluated by real-time three-dimensional transesophageal echocardiography. J Echocardiogr. 2013;11(2):77-9doi: 10.1007/s12574-013-0172-2.
Yamaguchi, R., Ota, T., Tanigawa, T., Sakai, M., Norioka, N., Ishikawa, S., Kawai, K., Nishiyama, H., Tsumori, T., Kamimori, K., & Yanagi, S. (2013). Cor triatriatum dexter with atrial septal defect evaluated by real-time three-dimensional transesophageal echocardiography. Journal of echocardiography, 11(2), 77-9. https://doi.org/10.1007/s12574-013-0172-2
Yamaguchi, Ryoko, et al. "Cor triatriatum dexter with atrial septal defect evaluated by real-time three-dimensional transesophageal echocardiography." Journal of echocardiography vol. 11,2 (2013): 77-9. doi: https://doi.org/10.1007/s12574-013-0172-2
Yamaguchi R, Ota T, Tanigawa T, Sakai M, Norioka N, Ishikawa S, Kawai K, Nishiyama H, Tsumori T, Kamimori K, Yanagi S. Cor triatriatum dexter with atrial septal defect evaluated by real-time three-dimensional transesophageal echocardiography. J Echocardiogr. 2013 Jun;11(2):77-9. doi: 10.1007/s12574-013-0172-2. Epub 2013 Mar 23. PMID: 27278516.
Copy Download .nbib Format: NLM
Editor's Notes.

Journal of medical ultrasonics (2001)

Kanai H.
PMID: 27279122
J Med Ultrason (2001). 2012 Oct;39(4):293. doi: 10.1007/s10396-012-0395-2.

No abstract available.

Cite
Kanai H. Editor's Notes. J Med Ultrason (2001). 2012;39(4):293doi: 10.1007/s10396-012-0395-2.
Kanai, H. (2012). Editor's Notes. Journal of medical ultrasonics (2001), 39(4), 293. https://doi.org/10.1007/s10396-012-0395-2
Kanai, Hiroshi. "Editor's Notes." Journal of medical ultrasonics (2001) vol. 39,4 (2012): 293. doi: https://doi.org/10.1007/s10396-012-0395-2
Kanai H. Editor's Notes. J Med Ultrason (2001). 2012 Oct;39(4):293. doi: 10.1007/s10396-012-0395-2. PMID: 27279122.
Copy Download .nbib Format: NLM
120 Gbit/s injection-locked homodyne coherent transmission of polarization-multiplexed 64 QAM signals over 150 km.

Optics express

Wang Y, Kasai K, Yoshida M, Nakazawa M.
PMID: 25607079
Opt Express. 2014 Dec 15;22(25):31310-6. doi: 10.1364/OE.22.031310.

We describe an injection-locked 64 QAM homodyne coherent transmission, which is the highest QAM multiplicity realized with an injection locking technique. The frequency locking range of the local oscillator (LO) was as wide as 1 GHz. The phase noise...

Cite
Wang Y, Kasai K, Yoshida M, et al. 120 Gbit/s injection-locked homodyne coherent transmission of polarization-multiplexed 64 QAM signals over 150 km. Opt Express. 2014;22(25):31310-6doi: 10.1364/OE.22.031310.
Wang, Y., Kasai, K., Yoshida, M., & Nakazawa, M. (2014). 120 Gbit/s injection-locked homodyne coherent transmission of polarization-multiplexed 64 QAM signals over 150 km. Optics express, 22(25), 31310-6. https://doi.org/10.1364/OE.22.031310
Wang, Yixin, et al. "120 Gbit/s injection-locked homodyne coherent transmission of polarization-multiplexed 64 QAM signals over 150 km." Optics express vol. 22,25 (2014): 31310-6. doi: https://doi.org/10.1364/OE.22.031310
Wang Y, Kasai K, Yoshida M, Nakazawa M. 120 Gbit/s injection-locked homodyne coherent transmission of polarization-multiplexed 64 QAM signals over 150 km. Opt Express. 2014 Dec 15;22(25):31310-6. doi: 10.1364/OE.22.031310. PMID: 25607079.
Copy Download .nbib Format: NLM
Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes.

Hepatology research : the official journal of the Japan Society of Hepatology

Higuchi Y, Kawai K, Kanaki T, Yamazaki H, Chesné C, Guguen-Guillouzo C, Suemizu H.
PMID: 26724677
Hepatol Res. 2016 Sep;46(10):1045-57. doi: 10.1111/hepr.12644. Epub 2016 Feb 07.

AIM: The hepatoma-derived cell line HepaRG is regarded as an in vitro model of drug metabolism because fully differentiated HepaRG cells demonstrate functional metabolic responses comparable to those of primary human hepatocytes. Recently, it was demonstrated that the 3D...

Cite
Higuchi Y, Kawai K, Kanaki T, et al. Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes. Hepatol Res. 2016;46(10):1045-57doi: 10.1111/hepr.12644.
Higuchi, Y., Kawai, K., Kanaki, T., Yamazaki, H., Chesné, C., Guguen-Guillouzo, C., & Suemizu, H. (2016). Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes. Hepatology research : the official journal of the Japan Society of Hepatology, 46(10), 1045-57. https://doi.org/10.1111/hepr.12644
Higuchi, Yichiro, et al. "Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes." Hepatology research : the official journal of the Japan Society of Hepatology vol. 46,10 (2016): 1045-57. doi: https://doi.org/10.1111/hepr.12644
Higuchi Y, Kawai K, Kanaki T, Yamazaki H, Chesné C, Guguen-Guillouzo C, Suemizu H. Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes. Hepatol Res. 2016 Sep;46(10):1045-57. doi: 10.1111/hepr.12644. Epub 2016 Feb 07. PMID: 26724677.
Copy Download .nbib Format: NLM
Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma.

Hepatology international

Ogasawara S, Kanai F, Ooka Y, Motoyama T, Suzuki E, Tawada A, Chiba T, Yokosuka O.
PMID: 26201804
Hepatol Int. 2013 Jun;7(2):703-13. doi: 10.1007/s12072-013-9425-4. Epub 2013 Feb 12.

PURPOSE: Sorafenib induces early vascularity reduction in patients with hepatocellular carcinoma (HCC). We sought to identify differences in radiological assessment approaches and to evaluate their usefulness for the prediction of the initial response to sorafenib.METHODS: Forty-eight patients with advanced...

Cite
Ogasawara S, Kanai F, Ooka Y, et al. Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma. Hepatol Int. 2013;7(2):703-13doi: 10.1007/s12072-013-9425-4.
Ogasawara, S., Kanai, F., Ooka, Y., Motoyama, T., Suzuki, E., Tawada, A., Chiba, T., & Yokosuka, O. (2013). Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma. Hepatology international, 7(2), 703-13. https://doi.org/10.1007/s12072-013-9425-4
Ogasawara, Sadahisa, et al. "Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma." Hepatology international vol. 7,2 (2013): 703-13. doi: https://doi.org/10.1007/s12072-013-9425-4
Ogasawara S, Kanai F, Ooka Y, Motoyama T, Suzuki E, Tawada A, Chiba T, Yokosuka O. Initial response to sorafenib by using enhancement criteria in patients with hepatocellular carcinoma. Hepatol Int. 2013 Jun;7(2):703-13. doi: 10.1007/s12072-013-9425-4. Epub 2013 Feb 12. PMID: 26201804.
Copy Download .nbib Format: NLM
Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report.

Oncology letters

Kawasaki K, Hamamoto Y, Adachi M, Kanai T, Takaishi H.
PMID: 26870193
Oncol Lett. 2016 Jan;11(1):231-233. doi: 10.3892/ol.2015.3905. Epub 2015 Nov 10.

Tumoral cavity formation is a characteristic phenomenon reported in anti-angiogenic therapy in lung lesions. A 57-year-old male with multiple pulmonary metastases from colorectal cancer treated with an oral tyrosine kinase inhibitor, regorafenib, exhibited a characteristic cavity formation after the...

Cite
Kawasaki K, Hamamoto Y, Adachi M, et al. Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report. Oncol Lett. 2015;11(1):231-233doi: 10.3892/ol.2015.3905.
Kawasaki, K., Hamamoto, Y., Adachi, M., Kanai, T., & Takaishi, H. (2016). Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report. Oncology letters, 11(1), 231-233. https://doi.org/10.3892/ol.2015.3905
Kawasaki, Kenta, et al. "Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report." Oncology letters vol. 11,1 (2016): 231-233. doi: https://doi.org/10.3892/ol.2015.3905
Kawasaki K, Hamamoto Y, Adachi M, Kanai T, Takaishi H. Early tumor cavitation with regorafenib in metastatic colorectal cancer: A case report. Oncol Lett. 2016 Jan;11(1):231-233. doi: 10.3892/ol.2015.3905. Epub 2015 Nov 10. PMID: 26870193; PMCID: PMC4727027.
Copy Download .nbib Format: NLM
ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis.

Cell reports

Takagi M, Uno H, Nishi R, Sugimoto M, Hasegawa S, Piao J, Ihara N, Kanai S, Kakei S, Tamura Y, Suganami T, Kamei Y, Shimizu T, Yasuda A, Ogawa Y, Mizutani S.
PMID: 25683718
Cell Rep. 2015 Feb 17;10(6):957-967. doi: 10.1016/j.celrep.2015.01.027. Epub 2015 Feb 12.

Ataxia-telangiectasia (A-T) patients occasionally develop diabetes mellitus. However, only limited attempts have been made to gain insight into the molecular mechanism of diabetes mellitus development in A-T patients. We found that Atm

Cite
Takagi M, Uno H, Nishi R, et al. ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis. Cell Rep. 2015;10(6):957-967doi: 10.1016/j.celrep.2015.01.027.
Takagi, M., Uno, H., Nishi, R., Sugimoto, M., Hasegawa, S., Piao, J., Ihara, N., Kanai, S., Kakei, S., Tamura, Y., Suganami, T., Kamei, Y., Shimizu, T., Yasuda, A., Ogawa, Y., & Mizutani, S. (2015). ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis. Cell reports, 10(6), 957-967. https://doi.org/10.1016/j.celrep.2015.01.027
Takagi, Masatoshi, et al. "ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis." Cell reports vol. 10,6 (2015): 957-967. doi: https://doi.org/10.1016/j.celrep.2015.01.027
Takagi M, Uno H, Nishi R, Sugimoto M, Hasegawa S, Piao J, Ihara N, Kanai S, Kakei S, Tamura Y, Suganami T, Kamei Y, Shimizu T, Yasuda A, Ogawa Y, Mizutani S. ATM Regulates Adipocyte Differentiation and Contributes to Glucose Homeostasis. Cell Rep. 2015 Feb 17;10(6):957-967. doi: 10.1016/j.celrep.2015.01.027. Epub 2015 Feb 12. PMID: 25683718.
Copy Download .nbib Format: NLM
Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study.

United European gastroenterology journal

Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, Hirata K, Seino T, Matsushita M, Nishizawa T, Masaoka T, Kanai T.
PMID: 27403304
United European Gastroenterol J. 2016 Jun;4(3):380-7. doi: 10.1177/2050640615618043. Epub 2015 Nov 13.

BACKGROUND AND AIM: This prospective randomized study was designed to assess the efficacy of 10-day and 14-day rifabutin-based triple therapy as a third- or fourth-line rescue therapy.METHODS: Patients who failed first- and second-line eradication therapy were enrolled. H. pylori...

Cite
Mori H, Suzuki H, Matsuzaki J, et al. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European Gastroenterol J. 2015;4(3):380-7doi: 10.1177/2050640615618043.
Mori, H., Suzuki, H., Matsuzaki, J., Tsugawa, H., Fukuhara, S., Miyoshi, S., Hirata, K., Seino, T., Matsushita, M., Nishizawa, T., Masaoka, T., & Kanai, T. (2016). Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European gastroenterology journal, 4(3), 380-7. https://doi.org/10.1177/2050640615618043
Mori, Hideki, et al. "Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study." United European gastroenterology journal vol. 4,3 (2016): 380-7. doi: https://doi.org/10.1177/2050640615618043
Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, Hirata K, Seino T, Matsushita M, Nishizawa T, Masaoka T, Kanai T. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study. United European Gastroenterol J. 2016 Jun;4(3):380-7. doi: 10.1177/2050640615618043. Epub 2015 Nov 13. PMID: 27403304; PMCID: PMC4924440.
Copy Download .nbib Format: NLM
1.5μm, mode-hop-free full C-band wavelength tunable laser diode with a linewidth of 8 kHz and a RIN of -130 dB/Hz and its extension to the L-band.

Optics express

Kasai K, Nakazawa M, Tomomatsu Y, Endo T.
PMID: 29041500
Opt Express. 2017 Sep 04;25(18):22113-22124. doi: 10.1364/OE.25.022113.

We demonstrate a narrow-linewidth, low-intensity noise, widely wavelength-tunable LD for which we adopted a long external cavity configuration (ECLD) with a tunable optical filter. By employing a simultaneous tuning circuit between the optical filter and the Fabry-Perot mode caused...

Cite
Kasai K, Nakazawa M, Tomomatsu Y, et al. 1.5μm, mode-hop-free full C-band wavelength tunable laser diode with a linewidth of 8 kHz and a RIN of -130 dB/Hz and its extension to the L-band. Opt Express. 2017;25(18):22113-22124doi: 10.1364/OE.25.022113.
Kasai, K., Nakazawa, M., Tomomatsu, Y., & Endo, T. (2017). 1.5μm, mode-hop-free full C-band wavelength tunable laser diode with a linewidth of 8 kHz and a RIN of -130 dB/Hz and its extension to the L-band. Optics express, 25(18), 22113-22124. https://doi.org/10.1364/OE.25.022113
Kasai, Keisuke, et al. "1.5μm, mode-hop-free full C-band wavelength tunable laser diode with a linewidth of 8 kHz and a RIN of -130 dB/Hz and its extension to the L-band." Optics express vol. 25,18 (2017): 22113-22124. doi: https://doi.org/10.1364/OE.25.022113
Kasai K, Nakazawa M, Tomomatsu Y, Endo T. 1.5μm, mode-hop-free full C-band wavelength tunable laser diode with a linewidth of 8 kHz and a RIN of -130 dB/Hz and its extension to the L-band. Opt Express. 2017 Sep 04;25(18):22113-22124. doi: 10.1364/OE.25.022113. PMID: 29041500.
Copy Download .nbib Format: NLM
Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma.

Oncology letters

Ito Z, Takakura K, Suka M, Kanai T, Saito R, Fujioka S, Kajihara M, Yanagisawa H, Misawa T, Akiba T, Koido S, Ohkusa T.
PMID: 28599481
Oncol Lett. 2017 Jun;13(6):4799-4805. doi: 10.3892/ol.2017.6071. Epub 2017 Apr 21.

Patients with pancreatic ductal adenocarcinoma (PDA) typically succumb to mortality early, even following surgical resection. Therefore, prognostic factors associated with early mortality are required to improve the survival of patients with PDA following surgical resection. Carbohydrate sulfotransferase 15 (CHST15)...

Cite
Ito Z, Takakura K, Suka M, et al. Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Oncol Lett. 2017;13(6):4799-4805doi: 10.3892/ol.2017.6071.
Ito, Z., Takakura, K., Suka, M., Kanai, T., Saito, R., Fujioka, S., Kajihara, M., Yanagisawa, H., Misawa, T., Akiba, T., Koido, S., & Ohkusa, T. (2017). Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Oncology letters, 13(6), 4799-4805. https://doi.org/10.3892/ol.2017.6071
Ito, Zensho, et al. "Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma." Oncology letters vol. 13,6 (2017): 4799-4805. doi: https://doi.org/10.3892/ol.2017.6071
Ito Z, Takakura K, Suka M, Kanai T, Saito R, Fujioka S, Kajihara M, Yanagisawa H, Misawa T, Akiba T, Koido S, Ohkusa T. Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Oncol Lett. 2017 Jun;13(6):4799-4805. doi: 10.3892/ol.2017.6071. Epub 2017 Apr 21. PMID: 28599481; PMCID: PMC5453115.
Copy Download .nbib Format: NLM
Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review.

OncoTargets and therapy

Oba T, Ono M, Iesato A, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ito K, Tateishi A, Yoshizawa A, Takayama F.
PMID: 27051299
Onco Targets Ther. 2016 Mar 18;9:1641-6. doi: 10.2147/OTT.S88726. eCollection 2016.

Lipid-rich carcinoma (LRC) of the breast is a rare breast cancer variant that accounts for

Cite
Oba T, Ono M, Iesato A, et al. Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review. Onco Targets Ther. 2016;9:1641-6doi: 10.2147/OTT.S88726.
Oba, T., Ono, M., Iesato, A., Hanamura, T., Watanabe, T., Ito, T., Kanai, T., Maeno, K., Ito, K., Tateishi, A., Yoshizawa, A., & Takayama, F. (2016). Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review. OncoTargets and therapy, 91641-6. https://doi.org/10.2147/OTT.S88726
Oba, Takaaki, et al. "Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review." OncoTargets and therapy vol. 9 (2016): 1641-6. doi: https://doi.org/10.2147/OTT.S88726
Oba T, Ono M, Iesato A, Hanamura T, Watanabe T, Ito T, Kanai T, Maeno K, Ito K, Tateishi A, Yoshizawa A, Takayama F. Lipid-rich carcinoma of the breast that is strongly positive for estrogen receptor: a case report and literature review. Onco Targets Ther. 2016 Mar 18;9:1641-6. doi: 10.2147/OTT.S88726. eCollection 2016. PMID: 27051299; PMCID: PMC4807953.
Copy Download .nbib Format: NLM
True Vapor-Liquid-Solid Process Suppresses Unintentional Carrier Doping of Single Crystalline Metal Oxide Nanowires.

Nano letters

Anzai H, Suzuki M, Nagashima K, Kanai M, Zhu Z, He Y, Boudot M, Zhang G, Takahashi T, Kanemoto K, Seki T, Shibata N, Yanagida T.
PMID: 28671477
Nano Lett. 2017 Aug 09;17(8):4698-4705. doi: 10.1021/acs.nanolett.7b01362. Epub 2017 Jul 07.

Single crystalline nanowires composed of semiconducting metal oxides formed via a vapor-liquid-solid (VLS) process exhibit an electrical conductivity even without an intentional carrier doping, although these stoichiometric metal oxides are ideally insulators. Suppressing this unintentional doping effect has been...

Cite
Anzai H, Suzuki M, Nagashima K, et al. True Vapor-Liquid-Solid Process Suppresses Unintentional Carrier Doping of Single Crystalline Metal Oxide Nanowires. Nano Lett. 2017;17(8):4698-4705doi: 10.1021/acs.nanolett.7b01362.
Anzai, H., Suzuki, M., Nagashima, K., Kanai, M., Zhu, Z., He, Y., Boudot, M., Zhang, G., Takahashi, T., Kanemoto, K., Seki, T., Shibata, N., & Yanagida, T. (2017). True Vapor-Liquid-Solid Process Suppresses Unintentional Carrier Doping of Single Crystalline Metal Oxide Nanowires. Nano letters, 17(8), 4698-4705. https://doi.org/10.1021/acs.nanolett.7b01362
Anzai, Hiroshi, et al. "True Vapor-Liquid-Solid Process Suppresses Unintentional Carrier Doping of Single Crystalline Metal Oxide Nanowires." Nano letters vol. 17,8 (2017): 4698-4705. doi: https://doi.org/10.1021/acs.nanolett.7b01362
Anzai H, Suzuki M, Nagashima K, Kanai M, Zhu Z, He Y, Boudot M, Zhang G, Takahashi T, Kanemoto K, Seki T, Shibata N, Yanagida T. True Vapor-Liquid-Solid Process Suppresses Unintentional Carrier Doping of Single Crystalline Metal Oxide Nanowires. Nano Lett. 2017 Aug 09;17(8):4698-4705. doi: 10.1021/acs.nanolett.7b01362. Epub 2017 Jul 07. PMID: 28671477.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 1842 entries